Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Prevention Valuation: Fund Health, Not Just Sav...
By
Rene Pretorius
May 9, 2025
Prevention promises healthier lives, but how should we value it? Prevention valuation is critical for funding in value-based care systems. The proverb "
Optimizing Value-Based Drug Pricing in Japan with MARIE Framework
Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression
Cost-Effective Interventions for HIV, Malaria, Syphilis, and TB in 128 Countries
Toripalimab Evidence Journey in Cancer Care
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
Catalyzing Value-Based Care Through Patient-Centered Outcomes
Pharmaceutical Innovation and Market Access: Insights from Fast Company’s 202...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
South Africa’s Innovative Strategy for Cervical Cancer Prevention
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
« Previous
1
2
3
4
5
6
…
12
Next »